6533b82efe1ef96bd1293ebc

RESEARCH PRODUCT

Current management of atopic dermatitis and interruption of the atopic march.

Thomas HultschThomas HultschLawrence F. EichenfieldMark Boguniewicz

subject

medicine.medical_specialtyAllergyImmunologyCalcineurin InhibitorsAnti-Inflammatory AgentsDiseaseEczema Area and Severity IndexDermatitis AtopicAtopyPrevalenceImmunology and AllergyMedicineHumansSCORADAsthmamedicine.diagnostic_testbusiness.industryCalcineurinDisease ManagementAtopic dermatitismedicine.diseaseSkin CareDermatologyAsthmabody regionsCalcineurinDisease ProgressionDermatologic Agentsbusiness

description

Treatment of atopic dermatitis requires a comprehensive approach that includes evaluation of potential triggers and education of the patient and family regarding proper avoidance measures. Hydration of the skin and maintenance of an intact skin barrier remain integral to proper management. Although topical corticosteroids have been a mainstay of anti-inflammatory therapy, the newer topical calcineurin inhibitors offer advantages for treatment of this chronic, relapsing disease. Studies aimed at defining optimal combination therapy and early intervention might change the treatment paradigm for atopic dermatitis.

10.1016/j.jaci.2003.09.031https://pubmed.ncbi.nlm.nih.gov/14657844